First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38%
Updated: May 7, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

12.7m
-11%
Revenue
Dec 31, 2022 12.7m
Sep 30, 2022 14.3m
Jun 30, 2022 10.3m
Mar 31, 2022 7m
-117.2m
+41%
Operating Income
Dec 31, 2022 -117.2m
Sep 30, 2022 -199m
Jun 30, 2022 -175.3m
Mar 31, 2022 -144.2m
-75.5m
+34%
Net Income
Dec 31, 2022 -75.5m
Sep 30, 2022 -114.3m
Jun 30, 2022 -77.7m
Mar 31, 2022 -92.4m

Earnings Waterfall
Pear Therapeutics Inc

Revenue
12.7m USD
Cost of Revenue
-7.4m USD
Gross Profit
5.3m USD
Operating Expenses
-122.5m USD
Operating Income
-117.2m USD
Other Expenses
41.7m USD
Net Income
-75.5m USD

Income Statement
Pear Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022
Revenue
Revenue
4
N/A
7
+65%
10
+47%
14
+40%
13
-11%
Gross Profit
Cost of Revenue
(5)
(7)
(9)
(12)
(7)
Gross Profit
(1)
N/A
0
N/A
1
+369%
3
+134%
5
+99%
Operating Income
Operating Expenses
(110)
(144)
(176)
(202)
(122)
Selling, General & Administrative
(68)
(90)
(111)
(128)
(78)
Research & Development
(37)
(50)
(63)
(73)
(44)
Other Operating Expenses
(5)
(4)
(2)
0
0
Operating Income
(111)
N/A
(144)
-30%
(175)
-22%
(199)
-14%
(117)
+41%
Pre-Tax Income
Interest Income Expense
(4)
(5)
(5)
(6)
(4)
Non-Reccuring Items
0
0
0
(1)
(6)
Total Other Income
48
57
103
92
52
Pre-Tax Income
(67)
N/A
(92)
-39%
(78)
+16%
(114)
-47%
(75)
+34%
Net Income
Income from Continuing Operations
(67)
(92)
(78)
(114)
(75)
Net Income (Common)
(67)
N/A
(92)
-39%
(78)
+16%
(114)
-47%
(75)
+34%
EPS (Diluted)
-0.58
N/A
-0.67
-16%
-0.54
+19%
-0.82
-52%
-0.55
+33%

See Also

Summary
PEAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEAR stock valuation using valuation multiples.
Wall Street Estimates
PEAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.